Delivery Order SPE2DB20D3103-SPE2DB25FP7C4
- Not listed
- The Defense Logistics Agency awarded a delivery order contract valued at $1,596.50 to AmerisourceBergen Drug Corp for the supply of Zepbound 10 mg/0.5 mL pen (0.5 mL) on July 28, 2025. This is a firm fixed price, non-set-aside delivery order that will be performed in Conshohocken, Pennsylvania, with an ultimate completion date of July 29, 2025. The contract represents a single delivery of this diabetes treatment medication to support federal medical procurement needs. This delivery order falls...
- The Defense Logistics Agency awarded a delivery order valued at $10,090.60 to AmerisourceBergen Drug Corp for the supply of Zepbound 5 mg/0.5 mL pens on August 7, 2025. This firm fixed-price delivery order is non-competitive and represents a single shipment of the diabetes and weight management medication to support federal healthcare requirements. The contract will be fulfilled from AmerisourceBergen's location in Conshohocken, Pennsylvania, with an ultimate completion date of August 8, 2025....
- The Defense Logistics Agency awarded a delivery order valued at $29,615.89 to AmerisourceBergen Drug Corp for the supply of Zepbound 2.5 mg/0.5 mL pen injectors on July 28, 2025, with an ultimate completion date of July 29, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed price terms and represents a single delivery order transaction for the diabetes medication. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania, where the...
- The Defense Logistics Agency awarded a delivery order valued at $2,287.74 to AmerisourceBergen Drug Corp on August 5, 2025, for the supply of Zepbound 7.5 mg/0.5 mL pen injections. This is a firm fixed-price delivery order with no set-aside designation, demonstrating competitive award status. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of August 6, 2025. This delivery order is issued under...
- The Defense Logistics Agency awarded a $1,507.12 firm fixed price delivery order to AmerisourceBergen Drug Corp for Zepbound 5 mg/0.5 ml pen injectors on August 1, 2025, with an ultimate completion date of August 4, 2025. This non-set-aside contract represents a small-value delivery order for the diabetes and weight management medication under the company's larger pharmaceutical supply agreement with DLA. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, performed the...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 25, 2025, for the supply of Zepbound 5 mg/0.5 mL pen injectors with a ceiling value of $1,143.87 and an ultimate completion date of July 28, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and represents a continuation of the government's procurement of this diabetes medication through AmerisourceBergen's existing pharmaceutical supply contracts. The...
- The Defense Logistics Agency awarded a delivery order valued at $2,199.96 to AmerisourceBergen Drug Corp for Zepbound 5 mg/0.5 ml pen injectors on July 28, 2025, with completion scheduled for July 29, 2025. This is a firm fixed-price delivery order issued under a non-competitive set-aside arrangement, with performance occurring at the contractor's facility in Conshohocken, Pennsylvania. The award represents a single-transaction delivery of this diabetes medication to support federal healthcare...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,875.36 for Zepbound 10 mg/0.5 ml pens on August 4, 2025, with an ultimate completion date of August 5, 2025. This firm fixed-price contract, executed without a set-aside designation, represents a competitive award to the pharmaceutical distributor for diabetes medication supply. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a critical vendor within the federal...
- The Defense Logistics Agency awarded a $4.5K delivery order to AmerisourceBergen Drug Corp on July 28, 2025, for the supply of Zepbound 12.5 mg/0.5 mL pen injectors, with a completion date of July 29, 2025. This competitively awarded, firm fixed-price contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $1 billion through December 2026. The place of performance is located in Conshohocken, Pennsylvania,...
- The Defense Logistics Agency awarded a $1,306.78 firm fixed price delivery order to AmerisourceBergen Drug Corp on July 29, 2025, for the supply of Zepbound 5 mg/0.5 mL pens. This competitive award, with a completion date of July 30, 2025, represents a child delivery order under AmerisourceBergen's broader pharmaceutical supply arrangements with the federal government. The order will be fulfilled from the vendor's Conshohocken, Pennsylvania location, where the company operates as a major...
- SPE2DB20D3103Indefinite Delivery Contract
- SPE2DB20D3103-SPE2DB25FP7C4Delivery Order
The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,308.60 for Zepbound 10 mg/0.5 ml pens on July 31, 2025, with an ultimate completion date of August 1, 2025. This competitively awarded, firm fixed-price contract involves no set-aside designation and is being performed at the company's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a procurement of the injectable diabetes medication under the DLA's pharmaceutical supply chain operations. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999.999 billion and extends through December 2026. As a major pharmaceutical distributor and healthcare solutions provider, AmerisourceBergen Drug Corp supplies a comprehensive range of medications, vaccines, and medical supplies to support military healthcare systems, the Defense Health Agency, and other federal medical procurement needs. The firm fixed-price delivery order structure and competitive award reflect the company's established capability to meet federal pharmaceutical procurement requirements through open competition.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.3k | 7/31/25 |